Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | IPSC | AVTX | ||
| Company | Akebia Therapeutics | Century Therapeutics Inc | Avalo Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.4200 | 2.26 | 14.75 | ||
| High | 1.4500 | 2.30 | 15.11 | ||
| Low | 1.4099 | 2.19 | 13.73 | ||
| Latest | 1.4300 | 2.22 | 13.92 | ||
| Change | unch | -0.04 | -0.83 | ||
| % Change | unch | -1.77% | -5.63% | ||
| Volume | 2,379,700 | 769,900 | 742,000 | ||
| 20-Day Average Volume | 2,338,595 | 1,264,655 | 787,210 | ||
| Previous Close | 1.4300 | 2.26 | 14.75 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4117 | 2.29 | 14.66 | ||
| 20-Day Raw Stochastic | 44.07% | 40.51% | 14.47% | ||
| 20-Day Relative Strength | 51.43 | 48.92 | 45.18 | ||
| Weighted Alpha | -43.62 | +109.52 | +90.91 | ||
| Today's Opinion | 40% Sell | 64% Buy | 56% Sell | ||
| Previous Opinion | 40% Sell | 64% Buy | 24% Sell | ||
| Last Month's Opinion | 40% Sell | 64% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.78% since 04/17/26 | -14.62% since 04/17/26 | -3.53% since 04/17/26 | ||
| Low | 1.3900 on 04/23/26 | 2.19 on 04/24/26 | 13.73 on 04/24/26 | ||
| High | 1.4550 on 04/21/26 | 2.59 on 04/20/26 | 15.15 on 04/23/26 | ||
| 1-Month | |||||
| %Chg | +5.15% since 03/24/26 | -0.89% since 03/24/26 | +3.49% since 03/24/26 | ||
| Low | 1.3000 on 04/07/26 | 1.93 on 03/27/26 | 13.15 on 04/14/26 | ||
| High | 1.5950 on 04/15/26 | 2.64 on 04/15/26 | 18.47 on 04/06/26 | ||
| 3-Month | |||||
| %Chg | +5.15% since 01/23/26 | -8.26% since 01/23/26 | -11.62% since 01/23/26 | ||
| Low | 1.1400 on 02/20/26 | 1.65 on 02/06/26 | 13.04 on 02/05/26 | ||
| High | 1.6000 on 02/12/26 | 3.04 on 03/10/26 | 19.08 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | -52.81% since 10/24/25 | +284.55% since 10/24/25 | -20.77% since 10/24/25 | ||
| Low | 1.1400 on 02/20/26 | 0.44 on 11/17/25 | 13.04 on 02/05/26 | ||
| High | 3.2000 on 10/28/25 | 3.04 on 03/10/26 | 20.72 on 12/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 383,067 | 399,727 | 371,859 | ||
| Shares Outstanding, K | 267,879 | 180,057 | 26,714 | ||
| Annual Sales | 236,200,000 | 109,160,000 | 60,000 | ||
| Annual Net Income | -5,350,000 | -9,580,000 | -78,260,000 | ||
| Last Quarter Sales | 57,620,000 | 0 | 60,000 | ||
| Last Quarter Net Income | -12,240,000 | -19,180,000 | -13,720,000 | ||
| 60-Month Beta | 0.37 | 1.66 | 0.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 02/26/26 | -0.25 on 03/12/26 | -0.37 on 03/23/26 | ||
| Latest Earnings Date | 05/14/26 | 05/21/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||